Skip to main content
Tech.euFundingExplorerBeta

Lophius

T cell based diagnostic systems for the early diagnosis and immunomonitoring in the fields of transplantation;infectious and autoimmune diseases

Lophius has raised €9.7M across 5 funding rounds from 7 investors, most recently a Growth/Late round in Jul 2016. Based in Regensburg, Germany; founded 2008; active in Healthtech. Data as of 28 Oct 2026.

Regensburg, GermanyFounded 2008www.lophius.com ↗
Total raised
€9.7M
€9,744,583
Funding rounds
5
Investors
7
distinct backers
Active since
2008-10
latest 2016-07

Funding by year

EUR raised per year
Lophius — funding by year — interactive chart.
Data table
Lophius — funding by year
2008€419k
2010€1.6M
2011€1.4M
2014€2.0M
2016€4.3M

Signals

High confidence
Raise-next likelihood8
base rate 37% for Growth/Late
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood8
base rate 11% (2+ rounds)
  • ▲ 5 rounds raised
  • ▼ Old (18y) — past typical exit age
  • ▼ No recent equity round (debt-only or quiet)

Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

5 rounds

Related news

Similar companies

same sector or country

Global coverage: FundingData